Introduction
It is well known that pregnancy is associated with an increase in plasma cortisol and that especially in the third trimester the values attained resemble a state of adrenocortical hyperfunction (Kopelman & Levitz, 1970) . It has also been shown that the concentration of cortisol in cord blood reflects the maternal state although it is less than the corresponding maternal values and is also influenced by neonatal adrenal activity. Following delivery, plasma cortisol levels in infants fall as the maternal contribution disappears from the circulation and values from 3 to 7 days following birth reflect endogenous neonatal adrenocortical activity. The predisposition of infants of prediabetic or frankly diabetic mothers to develop hypoglycaemia has also been well documented. This is presumed to be due to a temporary beta-cell hyperplasia induced in the foetal islets by the maternal hyperglycaemia. Limited observations made on such infants have indicated that where normal sugar concentrations exist, cortisol concentration tends to be compensatorily elevated.
Case history
The mother, who had suffered from dyspnoea during pregnancy, was shown 6 weeks before parturition to have a lesion diagnosed radiologically as a carcinoma of the right main bronchus. The tumour was considered to be inoperable.
The baby was born prematurely, by spontaneous vaginal delivery, on 31 October 1970 at 34 weeks gestation. The Apgar score at 2 min was 5 and the birth weight was 3-49 kg (>97th centile). Hydramnios was observed and, because of oedema, the mother was given frusemide, (40 mg x 2) in the first 24 hr following delivery. Cyanosis and respiratory distress were present initially in the neonate although there had been neither maternal pyrexia nor evidence of foetal distress. The initial respiratory acidosis with Pco2 of 68 mmHg had resolved by 8 hr when the Pco2 was 40 mmHg, the baby having been nursed in an incubator with moderate oxygen concentrations. The chest X-ray was compatible with pulmonary oedema. Clinically, the baby appeared to be of 38 weeks' gestation and was oedematous. At 13 hr, hypoglycaemia developed, the baby having been 'twittery' with a faint Dextrostix reading. True glucose was less than 5 mg/100 ml. Treatment followed the normal pattern with intravenous dextrose being given for 48 hr without complication. At 48 hr the baby was also quite markedly icteric and serum indirect bilirubin rose to a maximum of 23 mg/100 ml by day 5, before falling. The infant remained 'fragile' for some time, tending to become cyanosed on handling, and weight loss continued until the eleventh day, after which time the infant steadily improved until discharge on day 14.
Methods and results
Investigations were undertaken in the mother and child to determine cortisol status and, in the case of the mother, glucose handling. Plasma 1 1-hydroxycorticoids ('cortisol') were determined using a micromodification of the procedure of Mattingly (1962), requiring only 0-2 ml plasma. Blood glucose was measured using a specific glucose oxidase procedure known to be virtually free from interference by other carbohydrate and non-carbohydrate-reducing substances including glutathione. Urinary 17-oxosteroid and total 17-oxogenic steroid excretions were estimated by the MRC recommended methods (Medical Research Council, 1969) , and the cortisol secretion rate by an isotope dilution procedure similar to that described by Cope & Black (1958 
Discussion
Using the method described, one of us (R.W.L.) has derived a normal range for plasma 'cortisol' concentrations before and lhr after administration of 50 jg Synacthen to infants 1, 3 and 5-7 days following birth. So too, an attempt has been made to define normal limits for maternal plasma cortisol concentrations at various times prior to and following delivery. These results have been used in interpreting the present findings and are shown in Table 2 .
The salient features in the case described are the state ofmaternal hyperadrenocorticism and disturbed glucose tolerance which persisted until the course of radiotherapy, and the neonatal hypoglycaemia associated with the appearance of a large baby of a diabetic mother. Diabetes or prediabetes in the mother could have explained the child's Cushingoid appearance and the subsequent hypoglycaemia but would not be sufficient alone to account for the subnormal plasma cortisol observed in the infant. On the contrary, an infant of such a diabetic mother exhibited a plasma cortisol of 64 tLg/100 ml during a hypoglycaemic episode. So too, the relative hyperadrenocorticism of pregnancy is insufficient to explain the findings, the present maternal cortisol values being above the established ranges, and that of the infant prior to Synacthen being below the lower normal limits.
It is postulated, therefore, that an over-production of corticotrophin in the mother would account for all the manifestations. The maternal plasma cortisol concentration would be elevated and this would tend to impair carbohydrate tolerance whilst also crossing the placenta and producing temporary pituitary/ adrenocortical suppression in the infant. The likelihood that maternal glucose concentrations would There is, however, some doubt as to the origin of the possible excess corticotrophin in the mother. Ectopic corticotrophin-producing tumours are associated with clinical features which were absent in this case, and the response following radiotherapy is usually poor. Another explanation in the present case is that the stress caused by the bronchial carcinoma induced an increase in the output of normal pituitary corticotrophin. This would also account for the observations and would perhaps be easier to reconcile with the restoration of clinical and biochemical normality following treatment. In any event, the patient is being seen at regular intervals, morning and evening plasma cortisol concentrations being monitored in an attempt to detect a possible recurrence of the condition. Estimations of plasma corticotrophin will be performed if elevated cortisol values are detected.
